MDGL vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

MDGL

50.7
AI Score
VS
BBIO Wins

BBIO

51.8
AI Score

Investment Advisor Scores

MDGL

51score
Recommendation
HOLD

BBIO

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MDGL BBIO Winner
Forward P/E 666.6667 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 71.2% 120.4% BBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 50.7/100 51.8/100 BBIO
Profit Margin -25.3% -97.0% MDGL
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

MDGL 1M: -4.9% · 3M: +0.6% BBIO 1M: -1.7% · 3M: +16.0%

Current Technical Phase

MDGL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $516.74

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.9 · Price: $81.50

Fundamentals Snapshot

Metric MDGL BBIO
Market Cap
Forward P/E 53.7 532.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.7% 1.2%
Gross Margin 0.9% 0.9%
Operating Margin -0.2% -0.4%
EPS -14.00 -3.52
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.